Ogen Oral Tablet 0.75Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Ogen: Oral tablet (0.75mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_5520.JPG
Ortho-Est 0.75mg Tab
Janssen Pharmaceuticals, Inc.
Pill Identification: WFHC 101 
Drug Image file DrugItem_4664.JPG
Ogen .625 Tab
Pfizer Inc.
Pill Identification: U 3772  |  U 3772
Drug Image file DrugItem_1054.JPG
Estropipate 0.75mg Tab
Teva Pharmaceuticals USA
Drug Image file DrugItem_3861.JPG
Estropipate 0.75mg Tab
Barr Laboratories Inc a Division of Teva USA
Pill Identification: barr  |  555 727
Drug Image file DrugItem_4372.JPG
Ortho-Est 0.75mg Tab
Women First Healthcare Inc
Pill Identification: WFHC 101 
Drug Image file DrugItem_15057.JPG
Estropipate 0.75mg Tab
Mylan Pharmaceuticals Inc.
Pill Identification: M E7 
Drug Image file DrugItem_1735.JPG
Estropipate 0.75mg Tab
Actavis US
Pill Identification: WATSON 414 

What is this Medicine?

ESTROPIPATE (es troe PIH pate) is an estrogen. It is mostly used as hormone replacement in menopausal women. It helps to treat hot flashes and prevent osteoporosis. It is also used to treat women with low hormone levels.

In-Depth Information
Select a Medication

Ogen .625 Tablet

NDC: 000093772
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Storage Information
Store below 77 degrees F
Ogen .625 Tablet
Drug Image file DrugItem_4664.JPG
Pfizer Inc.
Pill Identification: U 3772  |  U 3772
Shape: oblong
Color: yellow
Daily Life Interactions for Ogen .625 Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Minor Lifestyle Interaction
Grapefruit juice and Ogen .625 Tablet(Estropipate)
Grapefruit juice and Estrogens(Estropipate)
Grapefruit juice and grapefruit-containing foods may increase the side effects of estrogen in some females, such as nausea, breast tenderness, headache or fluid retention. There may be no interaction. Do not significantly change your grapefruit intake while taking estrogens for hormone replacement therapy or as part of hormonal birth control products. Report any unusual side effects, like unusual non-menstrual vaginal bleeding, promptly for evaluation.
Pregnancy & Lactation Information
First Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Second Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Third Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ogen

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5